| 17219201 |
Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
Konopka, B,
Janiec-Jankowska, A,
Czapczak, D,
Paszko, Z,
Bidziński, M,
Olszewski, W,
Goluda, C
|
J. Cancer Res. Clin. Oncol. |
2007 |
| 10866302 |
Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
Han, SY,
Kato, H,
Kato, S,
Suzuki, T,
Shibata, H,
Ishii, S,
Shiiba, K,
Matsuno, S,
Kanamaru, R,
Ishioka, C
|
Cancer Res |
2000 |
| 10555148 |
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association
Lee, JO,
Yang, H,
Georgescu, MM,
Di Cristofano, A,
Maehama, T,
Shi, Y,
Dixon, JE,
Pandolfi, P,
Pavletich, NP
|
Cell |
1999 |
| 9326929 |
PTEN1 is frequently mutated in primary endometrial carcinomas
Kong, D,
Suzuki, A,
Zou, TT,
Sakurada, A,
Kemp, LW,
Wakatsuki, S,
Yokoyama, T,
Yamakawa, H,
Furukawa, T,
Sato, M,
Ohuchi, N,
Sato, S,
Yin, J,
Wang, S,
Abraham, JM,
Souza, RF,
Smolinski, KN,
Meltzer, SJ,
Horii, A
|
Nat. Genet. |
1997 |
| 11948419 |
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity
Koul, D,
Jasser, SA,
Lu, Y,
Davies, MA,
Shen, R,
Shi, Y,
Mills, GB,
Yung, WK
|
Oncogene |
2002 |
![PTEN R130G [cytosol] icon](/icon/R-ICO-013990.svg){kind=icon}
